Literature DB >> 16762289

[Study of prescription-indication of proton pump inhibitors].

C de Burgos Lunar1, S Novo del Castillo, E Llorente Díaz, M A Salinero Fort.   

Abstract

OBJECTIVES: To evaluate the adaptation of Proton Pump Inhibitors (PPI) prescriptions to the indications in the literature. To determine which doctors, patients and prescriptions characteristics are related to a correct prescription and to measure their relative importance.
MATERIAL AND METHODS: Cross-sectional observational study of prescription indication in an Urban Primary Care Center. Simple Random Sampling was used from primary care center patients PPIs prescriptions between July and December of 2003. Non-electronic prescriptions (OMI-AP program) were excluded from the sample. 412 PPI prescriptions were necessary as sample size to obtain a 95% confidence with a 4.7% precision and a 50% expected proportion. Simple random sampling techniques were used.
RESULTS: Prescription was correct under adequacy criteria in 36.4% of the cases. The effect of the "hiatal hernia" and "user activity status" variables showed the major impact on results with an OR: 0.361 and 1.672 respectively. NSAID treated patients PPIs prescriptions matched adequacy criteria in 79.5% of the cases. "Prescription source" and "User activity status" variables gave the highest impact with an OR: 2.5 and 4.52, respectively.
CONCLUSIONS: The high percentage of non-adequate prescriptions together with the differences found between primary and specialized levels of attention, could suggest lack of knowledge of PPIs prophylactic indications and lack of coordination between different levels of attention that could be solved by creating common performing protocols.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762289     DOI: 10.1157/13088585

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  4 in total

Review 1.  Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.

Authors:  Nabil Sultan; Jose Nazareno; James Gregor
Journal:  Can J Gastroenterol       Date:  2008-09       Impact factor: 3.522

2.  [Evaluation of the incidence of upper gastrointestinal bleeding in Spain in relation to the taking of anti-ulcer agents].

Authors:  Carlos Alvarez-Ibáñez; María Mercedes Guerra-García
Journal:  Aten Primaria       Date:  2012-05-31       Impact factor: 1.137

3.  Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study.

Authors:  Miguel Santibañez Margüello; Roberto Garrastazu; Mario Ruiz-Nuñez; Jose Manuel Helguera; Sandra Arenal; Cristina Bonnardeux; Carlos León; Marc Miravitlles; Juan Luis García-Rivero
Journal:  NPJ Prim Care Respir Med       Date:  2016-09-08       Impact factor: 2.871

4.  [Facing a dilemma in elderly complex and vulnerable patients: to stop or not to stop prevention?]

Authors:  Laura Llobet Vila; Josep Maria Manresa Domínguez; José Manuel Carmona Segado; Alícia Franzi Sisó; Rosa Vallès Balasch; Isabel Martínez Díaz
Journal:  Aten Primaria       Date:  2017-12-06       Impact factor: 1.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.